My Natural Treatment was cited for marketing unapproved new drugs and misbranded products related to COVID-19 treatment and prevention, specifically thyme, black seed, eucalyptus, rosemary, and peppermint oil products sold through their website and Amazon Associates program. The company made claims that these products could mitigate, prevent, treat, diagnose, or cure COVID-19 in people, causing them to be classified as unapproved drugs under section 505(a) of the Federal Food, Drug, and Cosmetic Act and misbranded drugs under section 502. The FDA and FTC jointly reviewed the company's website and social media platforms and determined that introducing these products into interstate commerce violated multiple provisions of the FD&C Act, including sections 301(a), 301(d), and 301(k).